DARREL MORELAND: Open Payments
NPI 1316337272 · BELLEVUE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$352 in 17 payments from 9 companies in 2025. Trend: 2023 $247 · 2024 $585 · 2025 $352
Food & beverage: $352
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $96 |
| E.R. Squibb & Sons, L.L.C. | 3 | $68 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| Lundbeck LLC | 2 | $32 |
| Alkermes, Inc. | 1 | $27 |
| ABBVIE INC. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: ABILIFY ASIMTUFII, COBENFY, FANAPT, REXULTI, ARISTADA, VRAYLAR, Qelbree, TRINTELLIX.
Industry payments across NE — which companies pay providers there.
